Vocal Biomarkers Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI1852
Vocal Biomarkers Market size is expected to grow significantly from 2019 to 2025.
Growing prevalence of psychological and cardiovascular diseases will enhance the demand for vocal biomarkers market. High demand for minimally invasive procedures coupled with speedy recovery should fuel the vocal biomarkers industry growth in coming years. Furthermore, the vocal biomarker system compliant to Health Insurance Portability and Accountability Act (HIPAA) may serve as an effective technique. It serves as an alternative to present diagnostic methods such as MRI, X-Ray and CT scan. Such factors will render positive impact on vocal biomarkers market growth during the forecast timeframe.
Ongoing research offers scope for many applications of vocal biomarkers that is expected to fuel business growth. Research on application of vocal biomarkers in diagnosis of cognitive impairment, Parkinson’s disease, traumatic brain injury and respiratory diseases will provide lucrative growth opportunities for industry players. The technology is user-friendly and offers self-diagnosis and medication. Globally growing Parkinson’s disease prevalence will drive vocal biomarkers market in forthcoming years. According to the Parkinson’s Foundation, over 10 million individuals are living with Parkinson’s disease globally, that is expected to enhance industry growth. Complex process involved in vocal biomarkers might eventually hamper the business growth.
Vocal tremor segment will witness a significant growth during the forecast period. It is a neurological disorder that causes involuntary movement of muscles in the throat as well as in vocal chords. Growing prevalence of neurological disorder and growing application of vocal tremor in neurological disorder will further drive segmental growth.
Respiratory disorders segment will register robust growth over the coming years on an account of rising prevalence of respiratory diseases such as asthma. As per WHO data published in 2017 around 235 million people suffer from asthma. Ongoing research on use of vocal biomarkers in asthma is expected to boost segment growth over the coming years.
Hospitals and clinics segment will show a lucrative growth during the forecast timeline. In Minnesota Mayo Clinic is tracing vocal biomarkers to improve remote health monitoring of patients with heart disease. Clinic is working with Israeli company Beyond Verbal to test the voice of patients with coronary artery disease. Moreover, Humana, Aetna and Blue Cross Blue Shield Association are using vocal biomarkers to recognize depression and stress amongst callers. Such initiatives render positive impact on business growth.
North America vocal biomarkers market will grow significantly owing to well-established healthcare facilities as well as technological advancements in this region. Rising favorable reimbursement policies and increasing healthcare expenditure will prove beneficial for patients thus, should foster regional growth.
Companies operating in vocal biomarkers market include Beyond Verbal, Boston Technology Corporation, Cogito Corporation, IBM Corporation, Sonde Health and Microtest Health. Companies are majorly focusing on collaboration with university and new product launch. For instance, in June 2017, Beyond Verbal launched API to enable voice-based emotion detection with reference to virtual private assistants. The firm aims on voice recognition software to recognize human emotion, releasing a cloud-based API engine to integrate with virtual private assistants thus, favoring industry growth.
Vocal Biomarkers Market By Type, 2014-2025 (USD Million)
- Error rate
- Vocal rise or fall time
- Voice tremor
Vocal Biomarkers Market By Indication, 2014-2025 (USD Million)
- Psychiatric disorders
- Neurological disorders
- Respiratory disorders
- Cardiovascular disorders
- Depression and anxiety disorders
- Traumatic brain injury
- Cognitive impairment
Vocal Biomarkers Market By End-use, 2014-2025 (USD Million)
- Hospitals and clinics
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Beyond Verbal
- Boston Technology Corporation
- Cogito Corporation
- IBM Corporation
- Sonde Health
- Microtest Health
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.